1255 — TATA Health International Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$461.41m
- HK$469.35m
- HK$99.80m
Annual cashflow statement for TATA Health International Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | — | — | — |
| Source: | ARS | ARS | |||
| Standards: | HKAS | — | — | — | — |
| Status: | Final | Final | fx Preliminary | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | -69.1 | 4.1 | — | — | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.29 | -54.7 | — | — | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 46.2 | 51.6 | — | — | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.9 | 13 | — | — | — |
| Capital Expenditures | -1.08 | -0.886 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -38.7 | 8.81 | — | — | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -39.8 | 7.93 | — | — | — |
| Financing Cash Flow Items | 9.83 | 8.75 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 43.2 | -14 | — | — | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.47 | 6.91 | — | — | — |